132 related articles for article (PubMed ID: 17225470)
21. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers.
Malafaya PB; Stappers F; Reis RL
J Mater Sci Mater Med; 2006 Apr; 17(4):371-7. PubMed ID: 16617416
[TBL] [Abstract][Full Text] [Related]
22. An original method for studying in vitro the enzymatic degradation of cross-linked starch microspheres.
Hamdi G; Ponchel G; Duchêne D
J Control Release; 1998 Nov; 55(2-3):193-201. PubMed ID: 9795055
[TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide loaded albumin microspheres II. Release characteristics.
Vural I; Kaş HS; Hincal AA; Cavé G
J Microencapsul; 1990; 7(4):511-6. PubMed ID: 2125078
[TBL] [Abstract][Full Text] [Related]
24. Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres.
Thanoo BC; Sunny MC; Jayakrishnan A
J Pharm Pharmacol; 1993 Jan; 45(1):16-20. PubMed ID: 8094438
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
Dini E; Alexandridou S; Kiparissides C
J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
27. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents.
Balmayor ER; Tuzlakoglu K; Marques AP; Azevedo HS; Reis RL
J Mater Sci Mater Med; 2008 Apr; 19(4):1617-23. PubMed ID: 18214645
[TBL] [Abstract][Full Text] [Related]
28. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
[TBL] [Abstract][Full Text] [Related]
30. Effect of process variables on particle size of gelatin microspheres containing lactic acid.
Dinarvand R; Mahmoodi S; Farboud E
Pharm Dev Technol; 2004 Aug; 9(3):291-9. PubMed ID: 15458234
[TBL] [Abstract][Full Text] [Related]
31. In-vitro studies of enteric coated diclofenac sodium-carboxymethylcellulose microspheres.
Arica B; Arica MY; Kaş HS; Hincal AA; Hasirci V
J Microencapsul; 1996; 13(6):689-99. PubMed ID: 8933354
[TBL] [Abstract][Full Text] [Related]
32. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
Saravanan M; Bhaskar K; Maharajan G; Pillai KS
Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
[TBL] [Abstract][Full Text] [Related]
33. Cross-linked guar gum hydrogel discs for colon-specific delivery of ibuprofen: formulation and in vitro evaluation.
Das A; Wadhwa S; Srivastava AK
Drug Deliv; 2006; 13(2):139-42. PubMed ID: 16423802
[TBL] [Abstract][Full Text] [Related]
34. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.
Jameela SR; Jayakrishnan A
Biomaterials; 1995 Jul; 16(10):769-75. PubMed ID: 7492707
[TBL] [Abstract][Full Text] [Related]
35. Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer.
Chaurasia M; Chourasia MK; Jain NK; Jain A; Soni V; Gupta Y; Jain SK
AAPS PharmSciTech; 2006 Sep; 7(3):74. PubMed ID: 17025254
[TBL] [Abstract][Full Text] [Related]
36. Properties of tableted high-amylose corn starch-pectin blend microparticles intended for controlled delivery of diclofenac sodium.
Desai KG
J Biomater Appl; 2007 Jan; 21(3):217-33. PubMed ID: 16443630
[TBL] [Abstract][Full Text] [Related]
37. A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system.
Zhang X; Chen F; Ni J
Drug Deliv; 2009 Jul; 16(5):280-8. PubMed ID: 19538010
[TBL] [Abstract][Full Text] [Related]
38. Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release.
Rubino OP; Kowalsky R; Swarbrick J
Pharm Res; 1993 Jul; 10(7):1059-65. PubMed ID: 8378248
[TBL] [Abstract][Full Text] [Related]
39. Intra-articular delivery of genipin cross-linked chitosan microspheres of flurbiprofen: preparation, characterization, in vitro and in vivo studies.
Kawadkar J; Chauhan MK
Eur J Pharm Biopharm; 2012 Aug; 81(3):563-72. PubMed ID: 22595132
[TBL] [Abstract][Full Text] [Related]
40. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
Akbuğa J; Bergişadi N
J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
